Scribd Logo
Upload

Welcome to Scribd!

  • 90 views

    USP-NF Albumin Human

    Uploaded by

    youssuf

    Copyright:

    © All Rights Reserved
    Download as PDF, TXT or read online from Scribd

    USP-NF Albumin Human

    Uploaded by

    youssuf
    90 views1 page

    Copyright

    © © All Rights Reserved

    Available Formats

    PDF, TXT or read online from Scribd

    Did you find this document useful?

    Is this content inappropriate?

    Copyright:

    © All Rights Reserved
    Download as PDF, TXT or read online from Scribd
    Download as pdf or txt
    90 views1 page

    USP-NF Albumin Human

    Uploaded by

    youssuf

    Copyright:

    © All Rights Reserved
    Download as PDF, TXT or read online from Scribd
    Download as pdf or txt
    of 1

    11/6/2020 USP-NF Albumin Human

    Printed on: Fri Nov 06 2020, 15:33:11 pm


    Printed by: Shruti Kharidia
    O cial Status: Currently O cial on 06-Nov-2020
    O cial Date: O cial Prior to 2013
    Document Type: USP & NF
    DocId: 1_GUID-FC264F2B-D786-40D7-865D-D698D01C8D51_1_en-US
    Printed from: https://online.uspnf.com/uspnf/document/1_GUID-FC264F2B-D786-40D7-865D-D698D01C8D51_1_en-US
    © 2020 USPC

    Albumin Human
    DEFINITION
    Albumin Human conforms to the regulations of the federal Food and Drug Administration concerning biologics (640.80 to 640.86) (see
    Biologics 〈1041〉). It is a sterile, nonpyrogenic preparation of serum albumin obtained by fractionating material (source blood, plasma,
    serum, or placentas) from healthy human donors, the source material being tested for the absence of hepatitis B surface antigen. It is
    made by a process that yields a product that is safe for intravenous use. NLT 96% of its total protein is albumin. It is a solution
    containing, in each 100 mL, either 25 g of serum albumin osmotically equivalent to 500 mL of normal human plasma, or 20 g
    equivalent to 400 mL, or 5 g equivalent to 100 mL, or 4 g equivalent to 80 mL, and contains NLT 93.75% and NMT 106.25% of the
    labeled amount in the case of the solution containing 4 g in each 100 mL, and NLT 94.0% and NMT 106.0% of the labeled amount in
    the other cases. It contains no added antimicrobial agent, but may contain sodium acetyltryptophanate with or without sodium
    caprylate as a stabilizing agent. It has a sodium content of NLT 130 mEq/L and NMT 160 mEq/L. It has a heme content such that the
    absorbance of a solution, diluted to contain 1% of protein, in a 1-cm holding cell, measured at a wavelength of 403 nm, is NMT 0.25. It
    meets the requirements of the test for heat stability and for pH.

    ADDITIONAL REQUIREMENTS
    • PACKAGING AND STORAGE: Preserve in tight containers, and store at the temperature recommended by the manufacturer or indicated on the
    label.
    • EXPIRATION DATE: The expiration date is not later than 5 years after issue from manufacturer's cold storage (5°, 3 years) if labeling
    recommends storage between 2° and 10°; not later than 3 years after issue from manufacturer's cold storage (5°, 3 years) if labeling
    recommends storage at temperatures not higher than 37°; and not later than 10 years after date of manufacture if in a hermetically
    sealed metal container and labeling recommends storage between 2° and 10°.
    L
    • LABELING: Label it to state that it is not to be used if it is turbid and that it is to be used within 4 h after the container is entered. Label it
    IA
    also to state the osmotic equivalent in terms of plasma, the sodium content, and the type of source material (venous plasma, placental
    plasma, or both) from which it was prepared. Label it also to indicate that additional uids are needed when the 20-g/100-mL or 25-
    g/100-mL product is administered to a markedly dehydrated patient.
    IC

    Auxiliary Information- Please check for your question in the FAQs before contacting USP.

    Topic/Question Contact Expert Committee


    FF

    ALBUMIN HUMAN Kevin Carrick BIO32020 Biologics Monographs 3 -


    Director, Science & Standards, Biologics Complex Biologics and Vaccines

    Chromatographic Database Information: Chromatographic Database


    O

    Most Recently Appeared In:


    Pharmacopeial Forum: Volume No. 41(6)

    Page Information:

    USP43-NF38 - 104
    USP42-NF37 - 105
    USP41-NF36 - 95

    Current DocID: GUID-FC264F2B-D786-40D7-865D-D698D01C8D51_1_en-US

    https://online.uspnf.com/uspnf/document/1_GUID-FC264F2B-D786-40D7-865D-D698D01C8D51_1_en-US?source=TOC 1/1

    You might also like